Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for HEPARIN LOCK FLUSH
- Efficacy and Safety of Rivaroxaban in the Prevention of Venous Thromboembolism in Glioma Patients
- RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing
- The Effect of Exercise on Pharmacodynamics and Pharmacokinetics of a Single Dose of Unfractionated Heparin
- Efficacy of 5-fluorouracil and Low Molecular Weight Heparin in High-risk Pediatric Retinal Detachment
- Heparin Reversal With Two Different Protamine Ratios After Cardiopulmonary By-pass.
- Lovenox With Aspirin in Thawed Blastocyst Transfer
- Low Molecular Weight Heparin or no Treatment Following Cesarean Delivery
- Comparison Between Haparin and Herodin in HD
- Evaluation of the Efficacy and Safety of Interleucin-2 Combined With PD-1 Monoclonal Antibody and CAPOX in Preoperative Neoadjuvant Therapy for Locally Advanced Rectal Cancer - a Multicenter, Single-arm, Open-label Clinical Trail
- Bioequivalence Study to Compare Metformin / Vildagliptin (850 mg/50 mg) Versus Galvumet®
- Mesoglycan for Acute Hemorrhoidal Disease
- Phase 3 Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary Bypass
- Bioequivalence Study to Compare Metformin / Vildagliptin Versus Galvumet®
- BivaLirudin versUS Heparin in Extracorporeal Membrane Oxygenation
- Nebulized Heparin for Prevention of Acute Lung Injury in Smoke Inhalation Injury
- Postpartum Heparin Against Venous Thromboembolism: a Pilot Randomized Controlled Trial
- The Safety of Nafamostat Mesylate for Patients With High Risk Bleeding Undergoing Hemodialysis: A Pilot Study
- AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia
- A Randomized, Double-Blind Phase 2 Study of VLX-1005 Versus Placebo in Suspected Heparin Induced Thrombocytopenia
- HIP Fracture Oral thromboPROphylaxis (Hip PRO Pilot)
- Routine Versus Selective Protamine Administration to Reduce Bleeding Complications After Transcatheter Aortic Valve Implantation (POPular ACE TAVI)
- Effect of Different Heparinization Schemes on Prognosis of Intracranial Aneurysm
- Effect of Anesthetics on Cardiac Biomarkers in Mitral and Aortic Valve Replacement/Plasty
- Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPS
- Prednisolone Administration in Patients With Unexplained REcurrent MIscarriages
- Normal Saline Versus Heparin Intermittent Flushing for the Prevention of Occlusion in Port-a-Cath
- Heparin-free Extracorporeal Membrane Oxygenation Support During Clinical Lung Transplantation
- Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation
- Dose-adjustment of Enoxaparin by a Bayesian Pharmacological Approach in Pediatric Renal Transplant Recipients (OPTI-TREX)
- The Study of Reducing Adverse Effects After Radiofrequency Ablation Combined With Sclerotherapy
- Effects of Ticagrelor Versus Prasugrel on Coronary Microcirculation in Patients Undergoing Elective Percutaneous Coronary Intervention: Results of the PROtecting MICROcirculation During Coronary Angioplasty (PROMICRO)-3 Randomised Study
- Effectiveness of Anisodamine Hydrobromide Combined With Heparin for the Treatment of Critically Ill Patients With Septic Shock
- Apixaban vs Dual Antiplatet Therapy Study After Left Atrial Appendage Occlosure (ADALA)
- Evaluate the Efficacy and Safety of Various Treatment Schemes for Severe Fever With Thrombocytopenia Syndrome(SFTS)
- Low Dose Heparin Factorial Trial
- Nebulized Salbutamol Facilitate Management of Hyperkalemia Postreperfusion During Liver Transplantation
- Efficacy and Safety of Nafamostat Mesylate for ECMO Anticoagulation
- Viscoelastic Testing Guided Tissue Plasminogen Activator Treatment in Acute Respiratory Failure
- Ulinastatin Improves and Prevents Cardiac Dysfunction Induced by Cardiopulmonary Bypass
- Post-surgical Scars After the Use of CACIPLIQ20
- Ultrasound-Guided Serratus Anterior Plane Block Versus Erector Spinae Plane Block in Pediatric Cardiac Surgery
- Active-control Randomised Trial Comparing 4-factor Prothrombin Complex Concentrate With Frozen Plasma in Cardiac Surgery
- Rivaroxaban Plus Aspirin to Manage Recurrent Venous Thromboembolic Events
- Catheter-directed Thrombolysis in Intermediate-high Risk Acute Pulmonary Embolism
- The Role of Ketamine and Dexmedetomidine in Opioid-Sparing Analgesia
- Tranexamic Acid in Proximal Humeral Fractures
- Optimal Protamine Dosing for Heparin Reversal Following Cardiopulmonary Bypass
- Platelet Function in Patients With Ischemic Stroke Treated With Anti-thrombotic or Thrombolytic
- Efficacy and Safety of Avatrombopag for Treating TCP in HBV-ACLF Patients Receiving ALSS Treatment
- To Evaluate if Dexmedetomidine Infusion Provides Renal Protection in Patients Undergoing Coronary Artery Bypass Graft
- Impact of Topical Tranexamic Acid on Pre- and Post-operative Hemoglobin/Hematocrit
- Corheart 6 Left Ventricular Assist System Prospective, Multicenter, Single-arm Clinical Evaluation Trial
- Uterine Artery Doppler Changes After Vaginal Administration of Isosorbide Mononitrate In Patients With URPL
- Bivalirudin Versus Enoxaparin in Critically Ill COVID-19 Patients
- Early Administration of Heparin at FMC for PPCI of STEMI Patients
- A Phase I Study of the Co-administration of VLX-1005 and Argatroban in Healthy Human Subjects
- Multi-center RCT of IV Ketamine Efficacy and Safety in Chronic Daily Headaches
- Apixaban Prevents Portal Vein Thrombosis After Laparoscopic Splenectomy and Azygoportal Disconnection
- Chemoprophylaxis With Rivaroxaban for Lower Limb Deep Vein Thrombosis in Colorectal Cancer
- Cost-effectiveness Analysis Between Two Anticoagulation Strategies for Atrial Fibrillation in the Postoperative Period of Coronary Artery Bypass Graft Surgery
- Tinzaparin And Biomarkers After Neoadjuvant Treatment of Ovarian Cancer
- Combination of Inhaled DNase, Baricitinib and Tocilizumab in Severe COVID-19
- Bioequivalence Study of a Generic Enoxaparin Sodium to Clexane® After Single Subcutaneous Dose in Healthy Human Subjects
- Pharmacokinetic and Bioequivalence Comparison of Baclofen and Chlorzoxazone Administered Individually or Concurrently
- Heparin Solution Versus Anti-adhesion Barrier Gel for Intrauterine Adhesions Prevention After Operative Hysteroscopy
- Nebulised Heparin in Patients With COVID-19 Pneumonia
- Pretreatment With Unfractionated Heparin for ST Elevation Myocardial Infarction
- Hydroxychloroquine in Unexplained Recurrent Pregnancy Loss
- Efficacy and Safety for Different Regimen of VTE Pharmacoprophylaxis Among Severely Burn Patients
- Safety and Feasibility of Argatroban as Anticoagulant in Adults With ECMO
- Bladder Capacity as Objective Measure of Intravesical Treatment of Newly Diagnosed IC
- Modified Del Nido Versus Custodiol Cardioplegia For Myocardial Protection In Cardiac Surgery.
- Heparinization vs Salinization of the Peripheral Venous Catheter
- Intravenously Administered M6229 in Critically Ill Sepsis Patients
- Intranasal Heparin Treatment to Reduce Transmission Among Household Contacts of COVID 19 Positive Adults and Children
- Comparison of Biocompatibility of Plasmapheresis Procedures With Citrate and Heparin Anticoagulation
- The Effectiveness and Safety of 4% Sodium Citrate as a Lock Solution in Central Venous Hemodialysis Catheter
- Inhaled Heparin for Hospitalised Patients With Coronavirus Disease 2019 (COVID-19)
- A Study in Healthy Participants Investigating Biomarkers After Exposure to Heparin When Heparin is Administered in the Fasted State or After a High-fat Meal. Heparin, a Registered Drug, is an Anticoagulant (Blood Thinner) That Prevents the Formation
- A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE
- A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE
- UFH is the Most Used Anticoagulant in Hemodialysis, Decreasing the Risk of Clot Formation in the Circuit.
- SAVES-IBD: Safety & Efficacy of Aspirin vs. Standard of Care for VTE Prophylaxis After IBD Surgery
- High Dose Methylprednisolone Verses Low Dose in Correction of Congenital Acynotic Heart Disease
- Efficacy of Prolonged Anticoagulation for Primary Prevention of Venous Thromboembolic Disease in Autoimmune Hemolytic Anemia: a Prospective, Phase II, Randomized, Multicenter Study
- Efficacy and Safety of Apixaban in COVID-19 Coagulopathy Patients With Respiratory Severity Under Critical Care
- Acetylsalicylic Acid in COVID-19 (ASA-SARS)
- Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)
- Heparin Versus Normal Saline in Peripherally Inserted Central Catheter Lines
- The BeLimumab Antiphospholipid Syndrome Trial (BLAST)
- The Safety of Non-vitamin K Oral Anticoagulants Compared to Warfarin Early After Cardiac Surgery
- Venous Thromboembolism Prophylaxis After Gynecological Pelvic Cancer Surgery With Rivaroxaban vs Enoxaparin
- Effects of Low Molecular Weight Heparin Therapy With Soft-Mist Inhaler for COVID-19 Induced Hypoxemia
- Intravenous Versus Subcutaneous Administration of Low Molecular Weight Heparin for Thromboprophylaxis in Critically Ill Patients
- Ticagrelor in Post-transplant Patients With Pediatric Hepatic Artery Thrombosis (HAT)
- Safety and Efficacy of Argatroban Applicated in Anticoagulation of V-V ECMO
- HAI-Floxuridine, or Liver-Tx, Combined With 2nd Line Chemotherapy Versus 2nd Line Chemotherapy Alone for Patients With Colorectal Livermetasteses and Heavy Tumour Burden.
- Unfractioned Heparin for Treatment of Sepsis Caused by Abdominal Infection
- Anticoagulation Profile in Pregnant Women Treated With Three Times a Day of Low Molecular Weight Heparin (LMWH)
- Early Versus Late Post Caesarean Section Oral Anticoagulation Initiation and Risk of Maternal Complications in Patients With Mechanical Heart Valve Prosthesis
- Causes and Prevention of Thromboembolic Disease in Nephrotic Syndrome
- Nebulized Heparin for COVID19-associated Acute Respiratory Failure
- Intraoperative Insulin Administration at Cardiac Surgery for Diabetic Patients
- Acetylsalicylic Acid in the Prevention of Severe SARS-CoV2 Pneumonia in Hospitalised Patients With COVID-19
- Tinzaparin Lead-In to Prevent the Post-Thrombotic Syndrome
- Observation and Treatment of Pulmonary Microthrombosis in Childhood Pneumonia With Elevated D-dimer
- Comparison of Effectiveness and Complications of Catheter Lock Solutions in Non-tunneled Hemodialysis Catheters
- Safety & Efficacy of Low Dose Aspirin / Ivermectin Combination Therapy for Treatment of Covid-19 Patients
- Continuous Heparin Infusion to Prevent Catheter-related Thrombosis
- Assessing Effects of Heparin Priming and Pass Number on Tissue Quality of Fine Needle Biopsies
- LMWH for Treatment of Early Fetal Growth Restriction (HepaGrowth)
- Adoptive SARS-CoV-2 Specific T Cell Transfer in Patients at Risk for Severe COVID-19
- Sodium Citrate 4% Locking Solution for Children Requiring Home Parenteral Nutrition
- Impact of Colchicine and Low-dose Naltrexone on COVID-19
- Clinical Study With Ibrutinib and Venetoclax for Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia
- Enriched Heparin Anti COVID-19 Trial
- Effect of Tinzaparin on Inflammatory Biomarkers During the Acute Phase of Deep Vein Thrombosis
- Low Molecular Weight Heparin on the Adenomyosis Patients'IVF-ET Outcome
- Prospective Study on the Role of Intravenous Unfractionated Heparin Following Digital Replantation and Revascularization
- Nebulized Heparin for the Treatment of COVID-19
- Individual Dose Adjustment of Low-molecular-weight-heparin by Thromodynamics Test.
- Effect of Montelukast in Preventing Dengue With Warning Signs in Dengue Patients
- Evaluation of Prognostic Modification in COVID-19 Patients in Early Intervention Treatment
- Assessing Safety, Hospitalization and Efficacy of rNAPc2 in COVID-19
- Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy（ESAWAAPT）
- Factor Xa Inhibitor Versus Standard of Care Heparin in Hospitalized Patients With COVID-19 (XACT)
- The Effect of Platelet Rich Pasma on Strenal Healing Post Median Strenotomy in Patients Undergoing Open Heart Surgery
- Heparin Prophylaxis Dosing for Antepartum Hospitalizations (HEPDOSE)
- Inhaled Heparin for Hospitalised COVID-19 Patients
- Strategies for Protamine Dosing After Anticoagulation in Cardiovascular Surgery
- A Study of Hydroxychloroquine Sulfate in the Treatment of Recurrent Spontaneous Abortion With Antiphospholipid Syndrome
- Effect of Diclofenac Potassium Versus Prednisolone on Post-endodontic Pain and Pulpal IL-8 Expression
- Clinical Efficacy of Heparin and Tocilizumab in Patients With Severe COVID-19 Infection
- D-dimer Adjusted Versus Therapeutic Dose Low-molecular-weight Heparin in Patients With COVID-19 Pneumonia
- Rivaroxaban vs. Warfarin in CVT Treatment
- Standard vs High Dose of Unfractionated Heparin in the Incidence of Radial Artery Occlusion (DEFINITION) Trial.
- Low Dose Prednisone Therapy in Women With Recurrent Pregnancy Loss
- Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism
- Enoxaparin Bioequivalence Study in Acute Coronary Syndrome Patients
- Nebulised Heparin in Patients With Severe COVID-19
- Hamburg Edoxaban for Anticoagulation in COVID-19 Study
- Reduced Anticoagulation Targets in ECLS (RATE)
- Efficacy and Safety of Bivalirudin Versus Heparin During Coil Embolization in Patients With Ruptured Intracranial Aneurysms
- Nebulized Heparin in Severe Acute Respiratory Syndrome COVID-19
- Efficacy of Sofosbuvir Plus Ledipasvir in Egyptian Patients With COVID-19 Compared to Standard Treatment
- Steroids and Unfractionated Heparin in Critically Ill Patients With Pneumonia From COVID-19 Infection
- Clinical Trial of Ivermectin Plus Doxycycline for the Treatment of Confirmed Covid-19 Infection
- Concentration-effect Relationship of Enoxaparin for Thromboembolic Prevention
- FREEDOM COVID-19 Anticoagulation Strategy
- Nebulised Heparin to Reduce COVID-19 Induced Acute Lung Injury
- Improving Outcome in Subarachnoid Hemorrhage wIth Nadroparine
- Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE
- Tenecteplase in Patients With COVID-19
- Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO) Heparin Study
- Early Prophylactic Low-molecular-weight Heparin (LMWH) in Symptomatic COVID-19 Positive Patients
- Intranasal Heparin Tolerability Study
- CoV-Hep Study: Regional Anticoagulation Modalities in Continuous Venous Venous Hemodialysis in Patients With COVID-19
- Efficacy Assessment of Methylprednisolone and Heparin in Patients With COVID-19 Pneumonia
- Suloexide in the Treatment of Early Stages of COVID-19
- Improved Adherence With Extended Venous Thromboembolism Prophylaxis After Major Cancer Surgery
- Safety and Efficacy of Bivalirudin During Short-term Intervention of Non-infarction Related Artery After PPCI of STEMI
- Possibility to Stop Perdialytic Heparin Therapy in Hemodialysed Patients With HeprAN ™ Membrane and Treated by Long-term Anticoagulation With VKA
- Efficacy of Apixaban in Malignancy With Deep Venous Thrombosis
- Impact of Tissue Plasminogen Activator (tPA) Treatment for an Atypical Acute Respiratory Distress Syndrome (COVID-19)
- Hesperidin and Diosmin for Treatment of COVID-19
- Safety of Fondaparinux as Post Partum Thromboprophylaxis
- Anticoagulation in Patients Suffering From COVID-19 Disease The ANTI-CO Trial
- Prasugrel in Severe COVID-19 Pneumonia
- A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to (SARS-CoV-2) COVID-19 Pandemic
- ZEPLAST- PED: ZEro_PLASma Trial in Small Infants Undergoing Cardiac Surgery
- Efficacy of Addition of Fecal Microbiota Transplant (FMT) and Plasma Exchange to Tenofovir in Comparison to Monotherapy With Tenofovir in ACLF-HBV
- Pulmonary Embolism International THrOmbolysis Study-3
- Enoxaparin in COVID-19 Moderate to Severe Hospitalized Patients
- Pharmacokinetics and Bioequivalence of Rivaroxaban Tablet in Healthy Chinese Volunteers
- Effect of Anticoagulation Therapy on Clinical Outcomes in COVID-19
- High Versus Low LMWH Dosages in Hospitalized Patients With Severe COVID-19 Pneumonia and Coagulopathy
- Pharmacodynamic Equivalence of Ovine Enoxaparin to Lovenox®
- Full Dose Heparin Vs. Prophylactic Or Intermediate Dose Heparin in High Risk COVID-19 Patients
- Bladder Instillations Versus Onabotulinumtoxin A for Treatment of Interstitial Cystitis/Bladder Pain Syndrome
- Nebulized Heparin for the Treatment of COVID-19 Induced Lung Injury
- Anticoagulation Therapy After Splenectomy in Cirrhosis Patient
- Baricitinib Compared to Standard Therapy in Patients With COVID-19
- Safety and Efficacy of Therapeutic Anticoagulation on Clinical Outcomes in Hospitalized Patients With COVID-19
- Heparin vs Placebo for Cardiac Catheterization
- Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19
- Antithrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC)
- Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19
- Comparison of Two Doses of Enoxaparin for Thromboprophylaxis in Hospitalized COVID-19 Patients
- Protective Effect of Aspirin on COVID-19 Patients
- Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care
- Recombinant Human Fibroblast Growth Factor-2 (rhFGF-2) In Gingival Recession Defects
- Covid-19 Associated Coagulopathy
- Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE
- Effects of Different Concentrations of Pressurized-heparin Flushing Fluid on Coagulation and Platelet Function Monitored by the Sonoclot Analyzer
- Evaluation of Complication Rates Using Filter vs. Centrifuge and Heparin vs. Citrate Anticoagulation
- Trial Evaluating Efficacy and Safety of Anticoagulation in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort
- Assessment of Pleotropic Effect of Heparin Infusion Versus Subcutaneous Injection in Septic Shock Patients
- An Inflammatory Challenge Using Endotoxin
- Collagen-thrombin Matrix Efficacy During Cardiac Surgery: a Prospective Randomized Controlled Trial
- Impact of Prophylactic Low-molecular Weight Heparin Dosing on Clotting Parameters Following Cesarean Delivery
- Evaluation of Regional Anticoagulation With Citrate in Extended Hemodialysis
- Extracorporal Photopheresis With UVADEX Plus Standard Steroid Treatment for High Risk Acute Graft-versus-host Disease
- HYDROxychloroquine in Syndrome Primary AntiPhospholipid
- Clinical Study of Argatroban in the Treatment of Acute Progressive Ischemic Stroke
- Anticoagulation-free VV ECMO for Acute Respiratory Failure
- Prophylactic Anticoagulation for Catheter-related Thrombosis
- mFOLFIRINOX Followed by Hepatic Arterial Infusion of Floxuridine and Dexamethasone With Systemic mFOLFIRI for Unresectable Liver-dominant Intrahepatic Cholangiocarcinoma
- Anticoagulation Medicine in Surgical Repair for Total Anomalous Pulmonary Venous Connection
- Postprandial Fatty Acid Metabolism in Subjects With Lipoprotein Lipase Deficiency
- Histidine-Tryptophan-Ketoglutarate Solution Versus Blood Cardioplegia in CABG
- Adenosine Versus Verapamil for Management of Supraventricular Tachycardia Post- Coronary Artery Bypass Grafting
- Effect of LOW-molecular-weight Heparin in Reducing Radial Artery Occlusion Rate After Transradial Coronary Catheterization
- Multi-center Application of Bivalirudin in Left Atrial Appendage Occlusion
- Evaluating Oral Peri-operative Acetylsalicylic Acid in Subjects Undergoing Endovascular Coiling-only of Unruptured Brain Aneurysms
- Bivalirudin in Late PCI for Oatients With STEMI
- Efficacy and Safety of Short-term Postoperative Anticoagulant Therapy to Prevente Thrombosis in Arterovenous Fistula
- Bilateral Pecto Intercostal Fascial Plane Block After Open Heart Surgeries
- Safety and Efficacy of Prolonged Use of Bivalirudin 4 Hours After ePCI (COBER Study)
- Bilateral Transversus Thoracic Muscle Plane Block as Analgesic in Open Heart Surgeries by US.
- Low Dose Thrombolysis, Ultrasound Assisted Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism
- PRACTECAL-PKPD Sub Study
- Radiation Dose in Humans From Orally Administered Tc99m-Heparin
- Rivaroxaban for the Prevention of Deep Vein Thrombosis in Patients With Left Iliac Vein Compression - The PLICTS Study
- Rivaroxaban and Vitamin K Antagonists for the Anticoagulation for the Implantation of Vena Cava Filters
- ACT Guided Heparinization During Open Abdominal Aortic Aneurysm Repair.
- Effect of Intravenous Iron Supplementation in Reducing Allogenic Blood Transfusion
- Bicarbonate vs Heparin Catheter Lock in Chronic Hemodialysis Patients
- Higher vs. Lower Dose Heparin for PCI
- Bivalirudin in Elderly Patients Undergoing Elective Percutaneous Coronary Intervention.
- A Study to Investigate the Effect of Triferic Plus Heparin Infusion Compared to Heparin Alone on Coagulation Parameters in Hemodialysis Patients
- Uterine Serous Carcinoma and Adjuvant Combined Intraperitoneal Chemotherapy and Radiation
- Cangrelor in Comatose Survivors of OHCA Undergoing Primary PCI
- Standard-dose Apixaban AFtEr Very Low-dose ThromboLYSis for Acute Intermediate-high Risk Acute Pulmonary Embolism
- Safety and Efficacy of Bivalirudin Versus Heparin for Systemic Anticoagulation in Extracorporeal Membrane Oxygenation
- Quantitative D-dimer Level and Anticoagulant Therapy in Idiopathic Intracranial Hypertension
- Prophylaxis Against Postoperative Atrial Fibrillation in Patients Undergoing On-pump CABG
- Papaverine vs Heparin for Peripheral Arterial Catheter Patency in Pediatric Patients
- Bivalirudin in Elderly Patients With Acute ST-segment Elevation Myocardial Infarction
- Study to Evaluate Safety and Efficacy of IBsolvMIR in Islet Transplantation
- Continuous Erector Spinea Block Versus Intravenous Analgesia in Coronary Bypass Surgery
- Safety and Efficacy of Extracorporeal Cytokine Hemoadsorption in Septic Shock in Critically Ill Cirrhotics
- Chemoprophylaxis Plus Early Ambulation
- Low Dose Catheter Directed Thrombolysis for Acute Pulmonary Embolism
- Resolution of Thrombi in Left Atrial Appendage With Edoxaban
- Clemastine in Cardiovascular Surgery
- Bivalirudin With Prolonged Full Dose Infusion Versus Heparin Alone During Emergency PCI
- Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study to Evaluate Safety and Efficacy of Danaparoid vs Argatroban
- Antibiotics as an Adjuvant in Patients With Acute Severe Ulcerative Colitis
- Systematic Evaluation of Protamine Doze in Cardiac Surgery
- Renaparin® in Kidney Transplantation
- Calcium Administration in Cardiac Surgery
- Sildenafil Citrate in Early Unexplained Recurrent Pregnancy Loss
- Comparison of 9 Doses vs 3 Doses of Post Operative Antibiotics in Live Liver Donors
- Comparison of Two Dosages of Heparin Before Extracorporeal Circulation
- Post Implantation Syndrome and Administration on NSAIDs in Patients Undergoing EVAR for AAA
- Bivalirudin vs Heparin in ECMO Patients
- Effect of LMWH on Pregnancy Outcome in Women With Multiple Failures of IVF-ET
- Liberal Versus Restrictive Fluid Protocols in Adults
- API-CAT STUDY for APIxaban Cancer Associated Thrombosis
- t-PA Prophylaxis to Prevent Catheter-associated Thrombosis and Infection
- Comparison of Anticoagulation Prolongation vs. no Anticoagulation in STEMI Patients After Primary PCI
- Vitamin C, Steroids, and Thiamine, and Cerebral Autoregulation and Functional Outcome in Septic Shock
- Identification of Compound Isolated From Cock's Comb and Its Effect on Arsenical Palmar Keratosis
- Heparin Intraoperative Instillation for Lower Urinary Tract Symptoms After Benign Hysterectomy
- Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion
- Outcomes of the Use of Sodium Bicarbonate (8.4%) Solution as a Catheter Lock Solution to Prevent Hemodialysis Catheter Loss Due to Lumen Clot Formation
- Efficacy, Safety and Pharmacokinetics of Tinzaparin During Slow Low Efficient Daily Dialysis in Intensive Care Patients
- Low Molecular Weight Heparin in Pregnancies With Unexplained Stillbirths
- Efficacy and Safety of Apixaban in the Treatment of Heparin Induced Thrombocytopenia (HIT)
- Vitamin C, Hydrocortisone and Thiamine for Septic Shock
- Study on Children Henoch-Schönlein Purpura Nephritis With TCM Multistep Treatment
- Effect of Anti-histamine in Prevention Systolic Hypotension After Protamine
- Edoxaban for the Treatment of Coagulopathy in Patients With Active Cancer and Acute Ischemic Stroke: a Pilot Study. (ENCHASE Study)
- Prolonged Enoxaparin in Primary Percutaneous Coronary Intervention
- Dual Antiplatelet Therapy For Shock Patients With Acute Myocardial Infarction
- Taurolock Hep 500 Versus Unfractionated Heparin as Anti-inflammatory in Hemodialysis Catheters.
- A Single Center Diagnostic, Cross-sectional Study of Coronary Microvascular Dysfunction
- Evaluation of Anti-Xa Levels in Surgery Patients Receiving Weight-based Heparin
- Low Dose Fat-Induced Insulin Resistance
- Efficacy of Dexmedetomidine Versus Clonidine to Control Delirium in Patients Undergoing CABG
- Direct Intra-arterial Thrombectomy in Order to Revascularize AIS Patients With Large Vessel Occlusion Efficiently in Chinese Tertiary Hospitals
- Vascular Boot Warming Program After Acute Deep Vein Thrombosis (DVT) ± Pulmonary Embolism (PE)
- Streptokinase Versus Unfractionated Heparin Nebulization in Severe ARDS
- Apixaban in End-stage Kidney Disease : A Pharmacokinetics Study
- Minimum Local Anesthetic Dose for Adductor Canal Block
- Comparision Between Activated Partial Thromboplastin Time Versus Anti-Xa Activity in Heparin Monitoring
- The Effect of Dexmedetomidine on Kidney Perfusion in Paediatric Patients
- Neutrolin Versus Heparin for Locking Hemodialysis Catheters
- TIPS or Anticoagulation in Portal Vein Thrombosis
- IVIg for Small Fiber Neuropathy With Autoantibodies TS-HDS and FGFR3
- Heparin Anticoagulation in Septic Shock
- The Effect of Glucocorticoid Therapy on Left Ventricular Remodelling in Acute Myocardial Infarction (RECONSIDER)
- Oral Tranexamic Acid vs. Oral Aminocaproic Acid to Reduce Blood Loss and Transfusion After Total Knee Replacement.
- Safety and Efficacy of LMWH Versus Rivaroxaban in Chinese Patients Hospitalized With Acute Coronary Syndrome
- Coronary Arteriogenetic Heparinized Exercise
- Weight-Based Enoxaparin Dosing and Real-Time Dose Adjustment in Orthopaedic Trauma
- Nebulized Heparin and Salbutamol in Mechanically Ventilated Patients With AECOPD
- Treatment of Intrauterine Growth Restriction With Low Molecular Heparin.
- Study Comparing Bivalirudin Versus Heparin in Neonatal and Pediatric ECMO
- Exploration of Anticoagulation Program in Cerebral Aneurysm and Arteriovenous Malformations With Hybrid Operation 2
- Optimal Cardiopulmonary Bypass and Anticoagulation Management Strategies in Obese Patients Undergoing Cardiac Surgery
- Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor
- Thromboprophylaxis in Patients Undergoing Orthopedic Surgeries; Comparison Between Rivaroxaban and Enoxaparin
- Rivaroxaban Versus Low-molecular-weight Heparin for Preventing Thrombosis in Cancer Patients
- Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism
- Low Molecular Weight Heparin (LMWH) vs Aspirin for Venous Thromboembolism (VTE) Prophylaxis in Orthopaedic Oncology
- A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism
- Sildenafil Versus Low Molecular Weight Heparin in Fetal Growth Restriction Treatment
- Effect of Intravenous Tranexamic Acid on Reduction of Blood Losses in Hip Fracture Patients
- Antithrombin Supplementation in ECMO
- Apixaban For Thromboprophylaxis In Patients With Acute Spinal Cord Injury
- Cangrelor vs. Ticagrelor for Early Platelet Inhibition in STEMI
- Study of Rivaroxaban for CeREbral Venous Thrombosis
- The Effects of Different Medical Marijuana Strains on Motor and Cognitive Function in People With Multiple Sclerosis
- Low Molecular Weight Heparin for the Prevention of Early TIPS Dysfunction
- Hydroxychloroquine for Prevention of Recurrent Miscarriage.
- Prevention of Radial Artery Occlusion After Transradial Access Using Nitroglycerin
- IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
- Multi-Center Single Arm Trial to Determine The Effectiveness of Warfarin Therapy Duration For Heparin-Induced Thrombocytopenia (HIT)
- Use of Protamine for Heparin Reversal After Catheter Ablation of Atrial Fibrillation
- Citrate 4% Versus Heparinised Saline in Preventing Peripherally Inserted Central Catheter (PICC) Occlusions
- AntiPhospholipid Syndrome Low-molecular-weight Heparin Pregnancy Loss Evaluation: The Pilot Study
- Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer (PROVE)
- Evaluation of the Efficacy of an inTerdialytic "Ethanol 40% v/v - enoxapaRin 1000 U/mL" Lock solutioN to Prevent Tunnelled Catheter Infections in Chronic Hemodialysis Patients
- Timing of VTE Prophylaxis in TBI
- MAGENTUM 1 HeartMate 3 LVAS: A Single Center Prospective Controlled Study (MAGENTUM 1)
- Islet Transplantation Using PKX-001
- Safety and Tolerability of Sodium Thiosulfate in Patients With an ACS Undergoing CAG Via Trans-radial Approach.
- PREvention of VENous ThromboEmbolism Following Radical Prostatectomy
- Pembrolizumab + Imprime PGG for Metastatic Non-small Cell Lung Cancer After Progression on First-Line Therapy: Big Ten Cancer Research Consortium BTCRC-LUN15-017
- Weight Adjusted Low Molecular Weight Heparin in Recurrent Implantation Failure: a Randomized Open Labeled Trial
- The Novel Immunomodulatory and Anticoagulant Therapies for Recurrent Pregnancy Loss
- Diagnosis and Treatment Strategy of Recurrent Spontaneous Abortion Associated With Thrombophilla
- PREVENTion of Clot in Orthopaedic Trauma
- A Study of the Safety and Pharmacokinetics of Apixaban Versus Vitamin K Antagonist (VKA) or Low Molecular Weight Heparin (LMWH) in Pediatric Subjects With Congenital or Acquired Heart Disease Requiring Anticoagulation
- Rivaroxaban or Aspirin for Biological Aortic Prosthesis
- Protamine Sulfate During Transcatheter Aortic Valve Implantation
- Evaluation of Anti-Xa Levels in Surgery Patients Receiving Fixed Dose Heparin
- Fixed Low-dose Heparin Versus Standard Adjusted-dose Heparin Infusion in Adults Receiving Venovenous ECMO With a Heparin Bonded Circuit.
- Panobinostat Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant for Patients With Refractory/Relapsed Lymphoma
- Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma
- LMWH Infusion as Anticoagulation for Home HD
- Apixaban for Routine Management of Upper Extremity Deep Venous Thrombosis
- Autologous Bone Marrow Stem Cells Infusion for the Treatment of Liver Diseases.
- The Effect of Cinnamon Cassia on Diabetes Control and Cardiometabolic Risk Factors in Adults With Type 2 Diabetes Mellitus
- Preoperative Administration of Heparin as Thromboprophylaxis in Major Thoracic Surgery
- Maintaining Patency in BioFlo Implanted Port Catheters With Saline Only Flushes
- A Study to Demonstrate Bioequivalence Between Insulin Glulisine U300 and Insulin Glulisine U100 After a Single Subcutaneous Dose Using the Euglycemic Clamp Technique, in Patients With Type 1 Diabetes Mellitus
- Mino-Lok Therapy (MLT) for the Treatment of CRBSI/CLABSI
- STAT-STatin and Aspirin in Trauma
- Bivalirudin in Acute Myocardial Infarction
- PGE1 as Additive Anticoagulant in ECMO-Therapy
- Management of Tunneled Catheter Thrombosis in Hemodialysis Patients: Prospective Study From Qatar
- Biological and Clinical Measurements Following Systemic Leakage When a Citrate or Heparin Lock is Used
- anti10a Levels in Women Treated With LMWH in the Postpartum Period
- Evaluation of the Amiens University Hospital Neuroradiology Anticoagulation Protocol
- The Impact of Intravenous Anaesthesia on Angiogenesis in Patients With Breast Cancer (TIVA/TCI-BC)
- The Efficacy and Safety of rhTNK-tPA in Comparison With Alteplase(Rt-PA) as Fibrinolytic Therapy of Acute STEMI
- Prophylactic Intravitreal 5-Fluorouracil and Heparin to Prevent PVR in High-risk Patients With Retinal Detachment.
- Topical Nitroglycerine Treatment for Radial Artery Spasm Prevention
- Impact of Apixaban on Clinical Outcome of the Patients With Large Vessel Occlusion or Stenosis Trial
- Randomized Anticoagulation Trial in Opcab (RATIO)
- Safety and Efficacy of Bemiparin in the Prevention of Thrombotic Events in Hospitalized Cirrhotic Patients
- Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)
- Steroids and Microcirculation In Cardiac Surgery
- Bemiparin Versus Enoxaparin in the Prevention of Venous Thromboembolism Among ICU Patients
- Bivalirudin in Stable Ischemic Heart Disease Patients Undergoing PCI
- PK Study of Multi-dose Trazodone Hydrochloride Prolonged-released Tablets in Healthy Chinese
- A Different Approach to Preventing Thrombosis
- Radial Artery Occlusion After Endovascular Procedure
- Study of The Therapeutic Benefits of Al-hijamah in Children With Beta Thalassemia Major
- Study of the Relationship Between Body Composition, Insulin Resistance and HDL Levels
- Efficacy Study of Thalidomide in Gastrointestinal Vascular Malformation Related Bleeding
- Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
- Anticoagulation in Cancer Related Stroke
- Cardio-respiratory Events and Inflammatory Response After Primary Immunization in Preterm Infants
- Effect Of Dexmedetomidine On Sublingual Microcirculation In Patients Undergoing On Pump CABG Surgery
- The Efficacy of Extract of Allium Cepae, Allantoin and Heparin in Patients With Proven Scar Development
- Effect of Intravenous Continuous Infusion Heparin on Rates of Venous Thromboembolism in High-Risk, Critically Ill Patients
- Comparison Between Xarelto Versus Warfarin in the Recanalization Rate of Deep Venous Thrombosis in Patients Legs.
- Real-time Anti-Factor Xa Measurements in Surgical Patients to Examine Enoxaparin Metabolism and Optimize Enoxaparin Dose
- Belinostat Combined With Azacitidine/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Refractory or Relapsed Lymphoma
- Evaluation of Extended Infusion Set Wear Using Medtronic Extended Wear Sof-set Infusion Set
- Effect of Melatonin on Cardiometabolic Risk- FULL
- Heparin Based on Ideal Body Weight for Cardiopulmonary Bypass in Obese Patients
- Effect of Hookworm Elimination and Vitamin A Intervention on Iron Status of Preschool Children in Sichuan, China
- Exposure of Salvaged Blood to Inflammation and Oxidative Stress: the Effect of Different Anticoagulant Regimes (HECICS)
- Low-molecular-weight Heparin in Constituted Vascular Intrauterine Growth Restriction
- Investigating Different Anticoagulants for Renal Replacement Therapy
- Venous Thromboembolism in Renally Impaired Patients and Direct Oral Anticoagulants
- The Application of Ticagrelor Combined With Low Molecular Weight Heparin During PCI
- Lipoprotein Lipase Enzyme Activity Assay Validation and Clinical Assessment
- Efficacy of Tranexamic Acid and Epsilon-aminocaproic Acid in Reducing Bleeding and Transfusions in Cardiac Surgery
- Efficacy and Safety of Unfractionated Heparin on Severe Sepsis With Suspected Disseminated Intravascular Coagulation
- Reprometabolic Syndrome Mediates Subfertility in Obesity
- Study Assessing Safety & Effectiveness of a Catheter Lock Solution in Dialysis Patients to Prevent Bloodstream Infection
- Blood Loss Reduction After Total Knee Arthroplasty. Comparison Topical Tranexamic Acid vs Platelet Rich Plasma
- Aspirin Versus Aspirin+Clopidogrel as Antithrombotic Treatment Following TAVI
- Efficacy, Safety and Tolerability of ISIS 304801 in People With Partial Lipodystrophy With an Open-Label Extension
- Treatment of Splanchnic Vein Thrombosis With Rivaroxaban. A Pilot, Prospective Cohort Study
- Phase 2 Evaluation of Multi-modality Algorithm for Non-metastatic Adenocarcinoma of Pancreas or Ampulla
- Comparison of Effectiveness and Safety of Three Lock Solutions for Long-Term Central Venous Catheter for Hemodialysis
- Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
- Low Molecular Weight Heparin to Improve Pregnancy Outcome in Patients With Recurrent Implantation Failure
- A New Anticoagulation Method Using Dalteparin in Quotidian and Nocturnal Home Hemodialysis Patients
- Efficacy and Safety of Half Dose Alteplase Added to Heparine, in Patients With Moderate Pulmonary Embolism
- The Effect of Intravenous Oxytocin Infusion Using Different Diluents on Neonatal Bilirubin & Sodium Levels
- Low Molecular Weight Heparin for 72 Hours Followed by Dabigatran for Acute Intermediate-Risk Pulmonary Embolism.
- Engage 24: Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
- Lenalidomide Combined With Vorinostat/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Diffuse Large B-Cell Lymphoma of the ABC Subtype
- Rivaroxaban in the Treatment of Venous Thromboembolism (VTE) in Cancer Patients
- Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer
- Apixaban as Treatment of Venous Thrombosis in Patients With Cancer: The CAP Study
- Efficacy of Ginseng for Patients on Regorafenib
- Therapeutic Anticoagulation Strategy for Acute Chest Syndrome
- Safety and Effectiveness of Novel Nitroglycerin Based Catheter Lock Solution
- High (100IU/Kg) Versus Standard (50IU/Kg) Heparin Dose for Prevention of Forearm Artery Occlusion
- Bivalirudin Infusion for Ventricular Infarction Limitation
- Rivaroxaban for Treatment in Venous or Arterial Thrombosis in Neonates
- Comparative Effectiveness of 30%TSC and Heparin Lock Solution in Hemodialysis Catheters
- Comparison of Bleeding Risk Between Rivaroxaban and Apixaban
- Trial of RiaSTAP Versus Cryoprecipitate to Lower Operative Transfusions
- Aralast NP in Islet Transplant
- Early Postoperative Administration of Oxycodone +/- Naloxone and Duration of Epidural Analgesia
- Heparin Versus Taurolidine to Bloodstream Infection Prevention Related in Central Venous Catheter in Children
- Romidepsin Maintenance After Allogeneic Stem Cell Transplantation
- XENITH: Rivaroxaban for Pulmonary Embolism Managed With Catheter Directed Thrombolysis
- Aneurysmal Subarachnoid Hemorrhage Trial RandOmizing Heparin
- Heparin for the Treatment of Burn Wound Pain
- Effects of Heparin on Arteriovenous Fistula Patency
- Pilot Feasibility and Safety of Administering Weight Adjusted Fixed LMWH Dose
- Rivaroxaban for Scheduled Work-up of DVT - The Ri-Schedule Study
- Effect of Deferiprone on Oxidative-Stress and Iron-Overload in Low Risk Transfusion-Dependent MDS Patients
- Optimized Heparin Regimen in Vascular Surgery
- Verapamil vs Heparin in Transradial Procedures
- Comparison of Topical and Infusion Tranexamic Acid After Total Knee Arthroplasty
- Comparison of Anticoagulation for All-comers Undergoing Percutaneous Coronary Revascularization Trial
- Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML)
- CINRYZE as a Donor Pre-treatment Strategy in Kidney Recipients of KDPI>60%
- Topical Nitroglycerin To Prevent Radial Artery Occlusion After Transradial Access: NTP-RAO Trial
- Safety and Efficacy of Clopidogrel in Locally Advanced and Metastatic Pancreatic Adenocarcinoma Treated With Chemotherapy
- Remifentanil Anesthesia and Postoperative BIS in Cardiac Surgery
- Aspirin and Enoxaparin for VTE in Trauma
- Effects of Low Molecular Weight Heparin Versus Dabigatran on Platelet Aggregation in Patients With Stable Coronary Artery Disease
- Study on Antithrombotic Prevention in Thrombophilia and Pregnancy Loss
- The SYMPTOMS - SYstematic Elderly Medical Patients Thromboprophylaxis: Efficacy on Symptomatic OutcoMeS - Study
- Hemorrhage Following Small Polyp Resection in the Colon in Anticoagulated Patients
- A Safety and Efficacy Study of BCD-080 Compared to Clexan for Deep Vein Thrombosis Prophylaxis at Orthopedic Surgeries
- Racial Differences in Vagal Control of Glucose Homeostasis
- A Randomized, Open-label, Three-arm Study of MZRW on Tolerability, Exposure and Pharmacokinetics
- rtPA in in the Prevention of CVAD-Associated Thrombosis and Infection in Pediatric Patients With Short Bowel Syndrome
- Dipeptidyl Peptidase-4 Inhibition and Narrow-band Ultraviolet-B Light in Psoriasis (DINUP)
- Single Dose PK of IV Tedizolid Phosphate in Morbidly Obese and Non-Obese Adults
- Pharmacokinetic Study of Lipo-PGE1 for Prevention of VOD After HSCT
- Determine the Safety/Efficacy of Ticagrelor for Maintaining Patency of Arterio-Venous Fistulae Created for Hemodialysis
- Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery
- Safety Study of Liver Regeneration Therapy Using Cultured Autologous BMSCs
- Timing of Initiation of LMWH Administration in Pregnant Women With APS
- Local Uterine Application of Low Molecular Weight Heparin (LMWH) in Intra-cytoplasmic Sperm Injection (ICSI)
- Bivalirudin vs Heparin in NSTEMI and STEMI in Patients on Modern Antiplatelet Therapy in SWEDEHEART
- Methylene Blue Intravenously and Chronic Neuropathic Pain
- Use of Warfarin After the First Trimester in Pregnant Women With APS
- Single Bolus Recombinant Nonimmunogenic Staphylokinase (FORtelyzin) Versus Single Bolus Tenecteplase (Metalyse) in STEMI
- Dabigatran Following Transient Ischemic Attack and Minor Stroke
- Ticagrelor Pharmacokinetics in NSTEMI
- ATAPAC Study (TauroLock Activity in Adult Cancer Patients)
- Impact on Morbidity and Mortality of Prophylactic Dosing of Low Molecular Heparin in Child-Pugh B Cirrhotic Patients
- TEG Anticoagulation Monitoring During ECMO
- OPtimal Timing of Thromboprophylaxis in Traumatic IntraCranial Haemorrhage - Pilot Study
- Effects of Anticoagulant Preventive Injection in Patients With Blood Cancer
- Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal Disconnection
- Recurrent Urinary Tract Infections and Heparin (RUTIH Trial)
- Warfarin Prevents Portal Vein Thrombosis in Liver Cirrhotic Patients With Hypersplenism After Laparoscopic Splenectomy
- Prophylactic Ethanol Lock Therapy (ELT) in Patients on Home Parenteral Nutrition
- Normal Saline Flushes at 12 vs 24 Hours Intervals for Maintaining Peripheral Intravenous Catheters Patency
- START-Register: Survey on Anticoagulated Patients Register
- Influence of Hyaluronic Acid on Bacillus Calmette-Guérin Local Side Effects
- Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of PER977 Following Heparin
- Clinical Trial of Deferasirox Combination Treatment With Deferiprone In Thalassaemia Patients
- Single Dose Administration of Alpha-1 Anti-Trypsin for the Amelioration of Organ Injury in Patients Undergoing Cardiac Surgery
- A Trial on Efficacy and Safety of Full Dose Tenecteplase Combined With Unfractionated Heparin (UFH) or Enoxaparin in Acute Myocardial Infarction (AMI) in the Prehospital Setting
- Full Dose Tenecteplase (TNK-tPA) Together With Heparin Sodium, Full Dose Tenecteplase With Enoxaparin, Half Dose Tenecteplase Together With Abciximab and Heparin Sodium in Patients With Acute Myocardial Infarction (AMI)
- ODSH + ICE Chemotherapy in Pediatric Solid Tumors
- Effect of a Multimodal Pain Regimen on Pain Control, Patient Satisfaction and Narcotic Use in Orthopaedic Trauma Patients
- Study of the Efficacy, Safety and Tolerability of Low Molecular Weight Heparin vs. Unfractionated Heparin in Stroke
- A Study of Subcutaneous Bevacizumab in Relapsed / Progressive Glioblastoma
- Enoxamed Study in the Treatment of Acute Coronary Syndromes
- DLBS1033 for Acute NSTEMI Without Early Coronary Revascularization
- Pregnancy Outcomes in Women With Unexplained Recurrent Pregnancy Loss Treated With Low Dose Aspirin and Unfractionated Heparin
- Impact of Low Dose Unfractionated Heparin Treatment on Inflammation in Sepsis
- Comparison of Antithrombotic Treatments After Aortic Valve Replacement. Rivaroxaban: A New Antithrombotic Treatment for Patients With Mechanical Prosthetic Aortic Heart Valve.
- Comparison of Ticagrelor And Clopidogrel on Inflammatory Biomarkers And Vascular Endothelial Function
- Tranexamic Acid Effect on Platelet Aggregation Following Infant Cardiopulmonary Bypass
- Carfilzomib/SAHA Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant in Myeloma
- The ImPact of Trimetazidine on MicrOcirculation After Stenting for Stable Coronary Artery Disease
- Feasibility Study of Unfractionated Heparin in Acute Chest Syndrome
- Tapered Warfarin or Interrupted Warfarin With Heparin Bridging for Pacemaker or Defibrillator Implantation
- 18F-deoxyglucose (FDG) PET-CMD
- Cancer Venous Thromboembolism (VTE)
- Comparing Anti-XA Levels in Post-Cesarean Patients Undergoing Enoxaparin Thromboprophylaxis
- A Pilot Study of ODSH in Acute Myeloid Leukemia
- Comparing Ticagrelor and Clopidogrel Pharmacodynamics After Thrombolysis
- OraL Crushed and dIspersed Ticagrelor 180mg Compared to Whole Tablets of eQUal Dose in STEMI Patients unDergoing Primary PCI: a Pharmacokinetic/Pharmacodynamic Study (the LIQUID Study)
- Rivaroxaban Versus Warfarin in Acute Ischemic Stroke With Atrial Fibrillation
- Treatment of Hemodialysis Catheter-Related Bacteremia
- Paclitaxel for the Treatment of Distal Radial Artery Arteriovenous Access Fistula Stenosis (PaciFIST-2)
- Low Remifentanil Target Controlled Infusions for Cardiac Surgery
- Assessment of Coronary Flow Reserve by Doppler Flow Wire in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention Differences Between the Loading Dose of Ticagrelor and Clopidogrel
- Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
- RCT Comparing Standard Cannula Delivered FS, UGFS and ClariVein® in the Management of SVI
- Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients With Diabetes (DIP): A Randomized Clinical Trial.
- Rivaroxaban for the Prevention of Venous Thromboembolism in Asian Patients With Cancer
- Efficacy Study to Evaluate B-Lock™ as an Antimicrobial Lock Solution in Dialysis Patients With a CVC
- Aza-SAHA-GBM With AutoSCT for Refractory Lymphoma
- Prospective Study on Preoperative Versus Postoperative Venous Thromboprophylaxis in Patients Undergoing Major Colorectal Surgery
- Use of Dabigatran Etexilate to Prevent Stroke and Thromboembolism
- Early Serum Infliximab Levels in Severe Ulcerative Colitis.
- Low Molecular Weight Heparin in Prevention of Recurrent Arteriovenous Graft Thrombosis in Chronic Hemodialysis Patients.
- Citrate Versus Heparin for the Lock of Non-tunneled Hemodialysis Catheters in Patients Hospitalised in ICU
- Comparison of Low-Molecular-Weight Heparin (LMWH) and Unfractionated Heparin (UFH) in Combination With Thrombolytic Treatment of Acute Massive Pulmonary Thromboembolism
- Pilot Safety Trial of Chemotherapy and Use of Heparin in Patients With Pancreatic Cancer
- Topical and Intravenous Administration of TXA Are Equally Effective in DAA THA
- The Effect of Tranexamic Acid on Transfusion Rates in Intertrochanteric Hip Fractures
- Randomized Comparison of Continuous and Intermittent Heparin Infusion During Catheter Ablation of Atrial Fibrillation
- Use of Tinzaparin for Anticoagulation in Hemodialysis
- Thalidomide to Overcome Lenalidomide Resistance After Autologous Hematopoietic Stem Cell Transplantation (HCT)
- Effects of Aspirin and Low Molecular Weight Heparin in IVF Outcome.
- Aspirin, Heparin and Miscarriage
- ENDOvascular Interventions With AngioMAX: The ENDOMAX Trial
- Pharmacokinetic Study of Recombinant AT III in Neonates Undergoing ECMO
- Donor Regulatory T Cells Infusion in Patients With Chronic Graft-versus-host Disease (GVHD)
- Nitroglycerin Infusion During Cardiac Surgery
- Paclitaxel for the Treatment of Upper-Extremity Arteriovenous Access Fistula Stenosis
- Clinical Effects of Eptifibatide Administration in High Risk Patients Presenting With Non-ST Segment Elevation Acute Coronary Syndrome (NSTE-ACS) Requiring Urgent Coronary Artery Bypass Graft Surgery in Short- and Long-Term Follow-up
- Safety and Efficacy of Heparin and Nadroparin in the Acute Phase of Ischemic Stroke
- TyrosIne Kinase Inhibitors in Chronic Myeloid Leukemia: Efficacy and Tolerability. The TIKlet Study
- Partial Thromboplastin Time After 72 Hours of Antithrombotic Prophylaxis Using Unfractionated Heparin
- Ph I Safety and Efficacy of ODSH in Patients Receiving Induction or Consolidation Therapy for Acute Myeloid Leukemia
- Citrate Versus Heparin Anticoagulation: Effect on Molecules Clearances
- Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy
- Balloon Aortic Valvuloplasty Performed Without Heparin to Decrease Vascular and Bleeding Complications of the Procedure
- Anticoagulation Length in Cancer Associated Thrombosis
- Validation of a Novel Dabigatran Based Peri-Operative Bridging Anticoagulation Protocol for Patients on Chronic Warfarin Therapy
- Normal Saline Versus Heparinized Solution Flush for Maintaining Patency of Peripheral Venous Catheters in Children
- Effect of Prasugrel Versus Clopidogrel on Platelet Function After Bivalirudin Cessation
- Interest of a Bi-truncal Nerve Block (Femoral + Sciatic) Extended, Systematically Associated With General Anesthesia, in the Femoropopliteal Bypass: Study of Post-operative Analgesia and Peripheral Circulation Downstream
- The Arterial Measurement of the Blood Flow Volume After Iloprost Stimulation
- Trial of Nebulized Heparin Versus Placebo for Inhalation Trauma
- Dabigatran Treatment Following Transient Ischemic Attack and Minor Stroke
- SST0001 (Roneparstat) in Advanced Multiple Myeloma
- The Effect of Nafamostat Mesilate in Prolonging Filter Patency With Patients on Continuous Renal Replacement Therapy
- This Study is Randomised, Single Oral Dose Bioequivalence Study of Meloxicam GSK 15 MG Tablets.
- Pomalidomide and Dexamethasone Effects in Multiple Myeloma Patients With Del 17p or t (4;14)
- Coagulation Profile in Patients Undergoing Video Assisted Thorascopic Surgery (VATS) for Lung Cancer
- On-treatment PLAtelet Reactivity-guided Therapy Modification FOR ST-segment Elevation Myocardial Infarction
- Argatroban in Critically Ill Patients With Heparin Resistance
- Venous Thromboembolic Prophylaxis After Trauma: Three Times a Day Unfractionated Heparin Versus Twice a Day Enoxaparin
- Compare VKA vs LMWH in Patients With Anticoagulation Criteria and Episode of Gastrointestinal Bleeding.
- Does Omega-3 Polyunsaturated Fatty Acids (PUFAs) Pretreatment Improve Outcomes in Patients Undergoing Percutaneous Coronary Intervention (PCI)?
- Preoperative Versus Postoperative Start With Thromboprophylaxis in THA (Total Hip Arthroplasty)
- Heparin Binding Protein in Patients With Acute Respiratory Failure Treated With GCSF (Filgrastim)
- BE Study of Metformin GSK 500mg
- Study in Cancer Patients With Central Line Associated Clots in the Upper Extremity Treated With Rivaroxaban (Catheter 2)
- Adjusted Value of Thromboprophylaxis in Hospitalized Obese Patients: A Comparative Study of Two Regimens of Enoxaparin
- Study of Individualized Therapies Selection for Patients With Metastatic Colorectal Carcinoma According to the Therapeutic
- Antithrombin III in Infants With Cardiopulmonary Bypass (CPB)
- Aspirin and Compression Devices for VTE Prophylaxis in Orthopaedic Oncology
- BivaliRudin in Acute Myocardial Infarction vs Glycoprotein IIb/IIIa and Heparin :a Randomised Controlled Trial.
- DEDICA (Dose of HEparin During Coronary Angioplasty) Trial
- Comparison of Anti-Xa Activity of ENOXA ® Versus LOVENOX ® in Acute Coronary Syndrome
- Prolonged Hemodialysis Catheter Survival With Copolymer Coating and Rt-PA
- A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
- Preconceptional Thromboprophylaxis in Recurrent PREGNANCY LOSSES Caused by Antiphospholipid Syndrome
- PHARMACODYNAMICS ASSESSMENT PRODUCT HEPARIN SODIUM (SUBCUTANEOUSLY) OF THE SWINE 5.000UI/ML OF BLAU FARMACÊUTICA S/A IN HEALTHY SUBJECTS IN COMPARISON OF SODIUM HEPARIN APP PHARMACEUTICALS
- PHARMACODYNAMICS ASSESSMENT PRODUCT HEPARIN SODIUM (INTRAVENOUSLY) OF THE SWINE 5.000UI/ML OF BLAU FARMACÊUTICA S/A IN HEALTHY SUBJECTS IN COMPARISON OF SODIUM HEPARIN APP PHARMACEUTICALS
- Heparin Anticoagulation to Improve Outcomes in Septic Shock: The HALO Pilot
- Revacept in Symptomatic Carotid Stenosis
- Antithrombotic Effects of Ticagrelor Versus Clopidogrel
- Erythrocyte-bound Apolipoprotein B After Withdrawal of Statin Therapy
- Heparin Dose for Radial Angiography
- The Effect of Low Dose Aspirin in Increasing the Chance of Pregnancy
- Efficacy and Safety of Acenocoumarol for Treatment of Nontumor Portal Vein Thrombosis in Cirrhosis of Liver
- Bemiparin as a Thromboprophylaxis After Gynaecological Surgeries
- Efficacy of RIvaroxaban for Prevention of Venous Thromboembolism After Knee Arthroscopy
- M402 in Combination With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer
- Using Intravenous Heparin Versus Standard of Care Subcutaneous Heparin to Prevent Clots After Surgery
- Low Molecular Weight Heparin in Recurrent Miscarriage With Negative Antiphospholipid Antibodies
- Reducing Post Operative Bleeding Following Cabg
- Understanding "Heparin Resistance" in Cardiac Surgery
- Rivaroxaban for Treatment of Patients With Suspected or Confirmed Heparin-Induced Thrombocytopenia
- ORSIRO Stents Versus Xience PRIME Stents Assessed by Optical Coherence Tomography
- An Evaluation of the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran Etexilate in Hemodialysis Patients
- Addition of Prednisolone and Heparin in Patients Undergoing IVF With Failed IVF Cycles
- OPtimal Timing of Thromboprophylaxis in Traumatic IntraCranial Haemorrhage (OPTTTICH Feasibility Study)
- ONE WEEK VERSUS FOUR WEEK HEPARIN PROPHYLAXIS AFTER LAPAROSCOPIC SURGERY FOR COLORECTAL CANCER.
- Comparison of 2 Low Molecular Weight Heparin as a Thromboprophylaxis Postpartum
- Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning
- Aspirin Versus Aspirin + ClopidogRel Following Transcatheter Aortic Valve Implantation: the ARTE Trial
- Bivalirudin Plus Stenting in Long Lesion to Avoid Periprocedural Myocardial Necrosis Trial
- Response of Recombinant Antithrombin in Heparin Resistant Patients Undergoing Cardiac Surgery
- Monitoring Renal Blood Flow With Contrast Enhanced Ultrasound During Coronary Angiogram
- Pot-Cast: Thrombosis Prophylaxis During Plaster Cast Lower Leg Immobilisation
- Pot-Kast: Thrombosis Prophylaxis After Knee Arthroscopy
- Antimicrobial Catheter Lock Solution for the Treatment of Central Line Associated Bloodstream Infection (CLABSI)
- Intracoronary Darbepoetin-alpha to Reduce The Infarct Size and Post-Infarct Remodeling
- Integrilin and Ilomedin in Combination in Comparison to Standard Treatment in Severe Pneumonia Patients With Severe Sepsis
- Low Dose Rt-PA for Acute Normotensive Pulmonary Embolism With RVD
- Antithrombin Enhancement May Improve Anticoagulation Efficiency in Infants Undergoing Cardiopulmonary Bypass for Cardiac Surgery
- Heparin Solution and INTEM/HEPTEM Analysis
- Study of the Effect of omega3 on Biomarkers of Cardiac Necrosis (CKMB and Troponin I) and Inflammation Marker (CRP) After Elective Percutaneous Coronary Intervention (PCI)
- Effect of Increased Free Fatty Acids on Leptin Function
- How Effective Are Antithrombotic Therapies in Primary Percutaneous Coronary Intervention
- Study to Assess the Pharmacodynamic Effects of Unfractionated Heparin (UFH) in Healthy Volunteers With and Without Bendavia
- Nafamostat Efficacy and Safety in Critically Ill Patients(NICE)
- Doxorubicin + BIBF 1120 in Patients for Ovarian Cancer
- Use of a Novel Catheter Lock Solution For Treatment of Hemodialysis Catheter Infections
- Ethanol Lock Therapy for Treatment and Secondary Prophylaxis of Central Line-Associated Bloodstream Infection
- Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
- Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies
- Novel Approaches in Preventing and Limiting Events III Trial (NAPLES III): Bivalirudin in High-risk Bleeding Patients
- Angiomax® or Unfractionated Heparin for Patients Undergoing Percutaneous Coronary Intervention
- Efficacy & Safety of ODSH (2-0, 3-0 Desulfated Heparin) in Patients With Metastatic Pancreatic Cancer Treated With Gemcitabine & Abraxane
- Effect of Replacement Volume of Haemodiafiltration and AST-120 on Toxins, Oxidative Stress and MicroInflammation
- Extended Peri-operative Tinzaparin to Improve Disease-free Survival in Patients With Resectable Colorectal Cancer
- The Effect of Heparin on Inhalation Injury
- The INtegrilin Plus STenting to Avoid Myocardial Necrosis Trial (INSTANT)
- Optimal Prophylactic Method of Venous Thromboembolism (VTE)
- Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery
- Exploring the Efficacy and Safety of Rivaroxaban to Support Elective Percutaneous Coronary Intervention
- Effects of Vitamin D on Renal Blood Flow, Proteinuria and Inflammation in Patients With Chronic Kidney Disease
- Vorinostat With Gemcitabine, Busulfan, and Melphalan With Stem Cell Transplant (SCT) in Relapsed or Refractory Lymphoid Malignancies
- Treatment of Sickle Cell Patients Hospitalized in Pain Crisis With Prophylactic Dose Low-molecular-weight Heparin (LMWH) Versus Placebo
- A Randomized Trial to Compare Busulfan + Melphalan 140 mg/m2 With Melphalan 200 mg/m2 as Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma
- Evaluation of the Clinical Practice of Using of a 70% Ethanol Lock Solution for the Prevention of Catheter Related Blood Stream Infections in Pediatric Patients Undergoing Intestinal Rehabilitation
- Foley Catheter Versus Cervidil for Induction of Labor at Term
- Efficacy and Safety of an Ethanol/Sodium Citrate Locking Solution: A Pilot Study
- Can Low Molecular Weight Heparin During Pregnancy With Intrauterine Growth Restriction Increase Birth Weight?
- Low Weight Heparin prOphylaxis for Placental-Mediated Complications of PrEgnancy
- A Phase 3 Clinical Study of KW-3357 in Patients With DIC
- A Clinical Study of KW-3357 in Patients With DIC
- Efficacy and Local Tolerability of Topically Applied Heparin on the Suitability of Newly Constructed Primary Arteriovenous Fistulas in Patients Planned for Haemodialysis
- Prevention of Thrombosis Recurrence in Patients With Low Circulating Levels of Antithrombin.
- Study to Evaluate Two Lenalidomide Dose Regimens With Low Dose Dexamethasone for the Treatment Relapsed Multiple Myeloma
- Aspirin Reload Before Percutaneous Coronary Intervention: Reperfusion Indexes Evaluation.
- Effects of Anesthetic Technique on Immune and Inflammatory Systems Following Radical Prostatectomy
- Safety and Efficacy of Lean Body Weight-based IV Heparin Dosing in Obese/Morbidly Obese Patients
- Gemcitabine/Capecitabine Followed by SBRT in Pancreatic Adenocarcinoma
- Patients With High-risk Acute Coronary Syndrome Without ST-segment Elevation
- Low Molecular Weight Heparin for Hemodialysis Anticoagulation
- Efficacy and Safety of the LovenoxTM (Enoxaparin) Versus HeparinTM Gynecologic Oncology Patients
- Trial of Two Central Venous Catheter (CVC) Flushing Schemes in Pediatric Hematology and Oncology Patients
- Comparison of Heparin Types; Efficacy and Safety
- Comparison of Subcutaneous Heparin and Enoxaparin for Deep Venous Thrombosis (DVT) Prophylaxis in Surgical Intensive Care Patients
- A Comparison of Dilute Versus Concentrated Heparin for CRRT Anticoagulation
- Epidural Versus Patient-controlled Analgesia for Reduction in Long-term Mortality Following Colorectal Cancer Surgery
- Role of Heparin in Poor Responders Undergoing In Vitro Fertilisation
- Reversal of Heparin in Patients Undergoing Percutaneous Coronary Intervention (PCI)
- Retrospective Registry of Patients With Acute Heparin-induced Thrombocytopenia Type II
- Open Label Use Of RiaStap During Aortic Reconstruction
- Diabetic Retinopathy Sulodexide Study
- Distinct Response of CD4+CD25+Foxp3+ and IL-10-secreting Type I T Regulatory Cells to Cluster Specific Immunotherapy in Allergic Rhinitis Children
- RiaSTAP vs. Conventional Transfusion in Patients Having Heart Valve Surgery
- PROSPER: PostpaRtum PrOphylaxiS for PE Randomized Control Trial Pilot
- Clinical Trial Comparing Heparin and Protamine Fixed and Titrated Doses in Cardiac Surgery With Cardiopulmonary Bypass
- Safety And Efficacy Of Lenalidomide As Maintenance Therapy In Patients With Newly Diagnosed Multiple Myeloma Following A Tandem Autologous-Allogeneic Transplant
- Trial of 70% Ethanol Versus Heparin to Reduce the Rate of Central Line Infections in Children With Short Bowel Syndrome
- Effect of Heparin on Femoral Arterial Sheaths Thrombosis During Diagnostic Coronary Angiography
- Dosing, Safety and Pharmacokinetic Profile of Rifabutin in Children Receiving Concomitant Treatment With Kaletra
- Effect of NCX4016 on Walking Distance in Patients With Peripheral Arterial Occlusive Disease (PAOD)
- Two Weeks of Low Molecular Weight Heparin for Distal Vein Thrombosis
- Significance of Antibodies to Heparin/Platelet Factor 4 Complex in Vein Graft Patency and Potential Role of Argatroban for Prevention of Vein Graft Occlusion
- Efficacy of Low Molecular Weight Heparin in Superficial Vein Thrombosis
- Aggrastat Truncated Length Against Standard Therapies in Percutaneous Coronary Intervention
- High-Dose Gemcitabine, Busulfan and Melphalan With Hematopoietic-Cell Support for Patients With Poor-Risk Myeloma
- Safety of Heparin in Patients With Septic Shock
- Comparison of Slow Efficiency Daily Dialysis (SLEDD) With Unfractionated Heparin Versus Citrasate in Critically Ill Patients.
- First-line Everolimus +/- Paclitaxel for Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma
- The Effect of Heparin in Treatment IVF-ET Failure
- Thrombolysis or Anticoagulation for Cerebral Venous Thrombosis
- High-Dose Gemcitabine, Busulfan and Melphalan for Patients With Refactory Hodgkin's Disease
- Normothermic Ex Vivo Lung Perfusion (EVLP) For An Improved Assessment of Donor Lungs For Transplantation
- ULTrasound Accelerated ThrombolysIs of PulMonAry Embolism
- Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism
- Study to Characterize the Effect of Heparin on Palifermin Activity
- Pilot/Ph I Safety and Efficacy of ODSH in Protein Losing Enteropathy Secondary to Single Ventricle Palliative Surgery
- Bivalirudin/Prasugrel Versus Abciximab/Clopidogrel in Patients Presenting With STEMI
- Antithrombin III Supplementation for Cardiopulmonary Bypass in Neonates
- The Effects of Lovaza® in Acute Myocardial Infarction
- Feasible Insulin Algorithm for Glycemic Control in Patients With Acute Coronary Syndrome
- Preventive Effect of Enoxaparin, Pentoxifylline and Ursodeoxycholic Acid to Radiation Induced Liver Toxicity
- Population Pharmacokinetics of Fentanyl in Patients Undergoing Living Donor Liver Transplantation
- Pocket Haematoma Prevention in Patients Who Required Implantation/Replacement of a Pacemaker or Implantable Cardiac Defibrillator. The PHP Study.
- Evaluation of Maintenance Dosing vs Loading Dosing Upon Restarting Warfarin Therapy: A Prospective Randomized Trial
- Contractubex Treatment in Scars After Abdominal Caesarean Section
- Effects of Valsartan and Aliskiren on Hemostatic Indices in Hypertensive Diabetics
- Switching Drug Therapy for the Prevention of Blood Clot Formation From Enoxaparin to Rivaroxaban After Orthopedic Surgery for Either Total Hip or Total Knee Replacement
- Multi-center Study to Investigate the Effects of Citrasate® on Heparin N Requirements During Hemodialysis Treatment
- European Ambulance Acute Coronary Syndrome (ACS) Angiography Trial
- EArly Discharge After Transradial Stenting of CoronarY Arteries in High-Risk Patients of Bleeding
- Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing Early Invasive Strategy
- DMSO Efficacy in IC/PBS Patients During and After Treatment
- Partial Thromboplastin Time During the First 24 Hours of Antithrombotic Prophylaxis Using Unfractionated Heparin (UFH)
- Dose Adjusting Enoxaparin Thromboprophylaxis Dosage According to Anti-factor Xa Plasma Levels Improve Pregnancy Outcome
- Dalteparin and Sunitinib Malate as First-Line Therapy in Treating Patients With Kidney Cancer That is Metastatic or Cannot Be Removed by Surgery
- HAI Abraxane With Gemcitabine and Bevacizumab
- Low-molecular-weight Heparin (LMWH) Versus Unfractionated Heparin (UFH) in Pregnant Women With Recurrent Abortion Secondary to Antiphospholipid Syndrome
- The Clinical Utility of Thrombelastography in Guiding Prophylaxis of Venous Thromboembolism Following Trauma
- B-Lymphocyte Immunotherapy in Islet Transplantation for Initial Islet Graft Failure
- A Trial of Intravesical Therapy for Interstitial Cystitis in Patients With Generalized Vulvodynia
- Heparin Resistance: Predictors and Outcomes
- The EFFect of hIgh Dose ClopIdogrel treatmENT in Patients With Clopidogrel Resistance
- Low-Molecular-Weight Heparin (LMWH) for Deep Venous Thrombosis (DVT) Prophylaxis
- Study to Assess OPB-31121 in Advanced Leukemias or Myelodysplastic Syndromes
- Comparative Study of ALX-0081 Versus GPIIb/IIIa Inhibitor in High Risk Percutaneous Coronary Intervention (PCI) Patients
- Heparin for Pregnant Women With Thrombophilia
- Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation
- Preoperative Ephedrine Attenuates the Hemodynamic Responses of Propofol During Valve Surgery: A Dose Dependent Study
- Retrospective Study of Patients Who Were Treated With Fondaparinux Pre-, Peri- and/or Postpartum for Prophylaxis or Treatment of Venous Thromboembolism
- Safety of Catheter Lock With or Without Heparin in Implanted Central Venous Catheters
- Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation
- Prevention of Maternal and Perinatal Complications by Enoxaparin in Women With Previous Severe Preeclampsia
- Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).
- Clinical Trial on Anti-inflammatory Effect of Low-Molecular Weight Heparin in Pediatric Cataract Surgery
- Tinzaparin for Primary Treatment and Extended Secondary Prophylaxis of Venous Thromboembolism in Patients With Cancer
- HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to Liver
- Double Filtration Plasmapheresis for Hepatitis C Virus (HCV) Genotype 1 Patients With High Viral Load
- Efficacy Study of Combined Prasugrel and Bivalirudin Versus Clopidogrel and Heparin in Myocardial Infarction
- Recombinant Streptokinase Versus Urokinase in Pulmonary Embolism in China (RESUPEC)
- Study Using Citrate to Replace Heparin in Babies Requiring Extracorporeal Membrane Oxygenation (ECMO)
- TIPPS: Thrombophilia in Pregnancy Prophylaxis Study
- Thromboprophylaxis for Patients Undergoing Surgical Resection for Colon Cancer
- Low Molecular Weight Heparin and/or Aspirin in Prevention of Habitual Abortion
- Prevention of Venous and Arterial Thromboembolism, in Cancer Patients Undergoing Chemotherapy, With a Low Molecular Weight Heparin (Nadroparin Calcium)
- Pediatric Ethanol Lock Therapy Study.
- Ertapenem Pharmacokinetics in Patients in Continuous Ambulatory Peritoneal Dialysis
- A Study of KW-3357 in Congenital Antithrombin Deficiency
- A Study Assessing the REG1 Anticoagulation System Compared Heparin in Subjects With Acute Coronary Syndrome
- PP13 and Doppler Study to Predict Preeclampsia
- Fondaparinux 1,5 mg for the Prevention of Venous Thromboembolism (VTE) in Medical Patients With Renal Insufficiency
- Adjunctive Cilostazol Versus High Maintenance-dose ClopidogrEL in Acute Myocardial Infarction (AMI) Patients According to CYP2C19 Polymorphism
- Safety Study of Desirudin, an Anticoagulant for the Prophylaxis of Thrombosis
- Evaluation of Fondaparinux in Patients With a Heart Rhythm Disturbance Who Undergo Restoration of Normal Heart Rhythm
- The Effects of Arixtra on Wound Drainage Following Total Joint Arthroplasty
- Efficacy and Safety of Sodium Heparin in Patients Submitted to Heart Surgery Using Bypass
- Nonmyeloablative Stem Cell Transplantation for Chronic Lymphocytic Leukemia (CLL)
- Prostacyclin's Effect on Platelet Responsiveness
- Cloxacillin as Prevention of Double Lumen Infection in Hemodialysis Patients
- The STREAM Percutaneous Coronary Intervention Anticoagulant Sub-study
- Heparin Versus no Heparin on Duration of Peripherally Inserted Central Catheter (PICC) Patency in Neonates
- Prophylactic Enoxaparin Dosing for Prevention of Venous Thromboembolism in Pregnancy.
- Side Effects Involving the Heart in Women With Breast Cancer Receiving Doxorubicin and Trastuzumab
- Enoxaparin as Treatment for Vulvodynia
- Clinical Management of Argatroban in Patients With Heparin Induced Thrombocytopenia Type II
- Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies
- Safety and Efficacy of Therapeutic Anticoagulation With Tinzaparin During Pregnancy Via Weight-based Dosing
- Comparative Study of Two Brands of Heparin Already on the Market
- A Study to Evaluate the Efficacy and Safety of Fondaparinux for the Prevention of Venous Blood Clots in Patients With a Plaster Cast or Other Type of Immobilization for a Below-knee Injury Not Needing Surgery
- ODiXahip - a Phase IIa Dose Escalating Proof of Principle Trial
- Enoxaparin and/or Minocycline in Acute Stroke
- The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma
- Effect of Intravesical Lidocaine on Urodynamic and Symptomatic Parameters of Interstitial Cystitis
- Randomized, Open Label Study of Dabigatran Etexilate in Elective Percutaneous Coronary Intervention
- Bone Resorption, Osteoclastogenesis and Adalimumab
- Azacitidine After Allo Blood And Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML)
- Eptifibatide and ST Segment Resolution Following Primary PCI
- Comparison Between Thrombolysis and Primary Percutaneous Coronary Intervention (PCI) to Treat ST-Segment Elevation Myocardial Infarction
- Bridge or Continue Coumadin for Device Surgery Randomized Controlled Trial
- 12-h and 2-h Urokinase Regimes of Pulmonary Thromboembolism in China
- Argatroban Versus Lepirudin in Critically Ill Patients
- Nadroparin for the Initial Treatment of Pulmonary Thromboembolism
- Fondaparinux Trial With Unfractionated Heparin (UFH) During Revascularization in Acute Coronary Syndromes (ACS)
- Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction
- Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation After Kidney Transplant
- Tirofiban and Enoxaparin in High Risk Coronary Intervention
- A Study of the Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary Bypass Surgery Receiving Routine Mechanical Prophylaxis
- Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation
- A Comparative Sudy Comparing Argatroban® IV vs Desirudin SC for Suspected HIT With or Without Thrombosis Syndrome
- Effectiveness of Bridging Anticoagulation for Surgery (The BRIDGE Study)
- Chemotherapy With or Without Enoxaparin in Pancreatic Cancer
- Heparin and the Reduction of Thrombosis (HART) Trial
- The Effects of Omega-3 Fatty Acids on Aspirin Resistance
- Enoxaparin Low Molecular Weight Heparin (LMWH) in Advanced Non Small Cell Lung Cancer: Effect on Survival and Symptom Control in Patients Undergoing First Line Chemotherapy (SYRINGES)
- Anticoagulation Post Laparoscopic Splenectomy
- Prophylaxis Against DVTs After Primary Hip and Knee Replacement Surgery
- Bivalirudin PCI Registry in Heparin Induced Thrombocytopenia/Heparin Induced Thrombocytopenia and Thrombosis Syndrome (HIT/HITTS) Patients
- Low Molecular Weight Heparin in Recurrent Implantation Failure
- Prevention of Unexplained Recurrent Abortion by Enoxaparine
- Free Fatty Acid-Induced Hypertension in Obese Subjects With Type 2 Diabetes
- Reduced Dose of Unfractionated Heparin in Patients Undergoing PCI
- Parnaparin vs Aspirin in the Treatment of Retinal Vein Occlusion
- Alterations of Blood Clotting With the Use of Sequential Compression Devices on the Lower Limbs
- Randomized Study of the Use of Warfarin During Pacemaker or ICD Implantation in Patients Requiring Long Term Anticoagulation
- STEMI Treated With Primary Angioplasty and Intravenous Lovenox or Unfractionated Heparin (UFH)
- Overall Survival of Inoperable Gastric/GastroOesophageal Cancer Subjects on Treating With LMWH + Chemotherapy(CT) vs Standard CT
- A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer
- Phase I Clinical Study of the Safety of Photodynamic Therapy (PDT) Using LS11 in Children With Plexiform Neurofibromas
- Feasibility and Safety Study Comparing REG1 Anticoagulation System With Unfractionated Heparin in Elective PCI
- Sodic Heparin Effectiveness of the Treatment of Burns
- Prevention of Venous Thromboembolism in Patients With Acute Primary Intracerebral Hemorrhage
- Long-Term Low-Molecular-Weight Heparin Versus Oral Anticoagulants in Deep Venous Thrombosis
- Intravenous Versus Intracoronary Use of Abciximab
- Cardiac Surgery: In Vivo Titration of Protamine
- Prevention of Gastrointestinal Bleeding in Patients With Severe Ischemic Heart Disease
- Thrombophylaxis in Transurethral Surgery With Dalteparine
- Ethanol Locks for the Treatment of Central Venous Line Infections
- Fondaparinux for the Treatment of Heparin-Induced Thrombocytopenia (HIT)
- OPG and RANKL Plasma Level After Administration of Unfractionated Heparin (UFH) and Low-Molecular-Weight Heparin (LMWH) in Hemodialysis
- Anticoagulant Treatments and Percutaneous Coronary Angioplasty
- Warfarin After Anterior ST-Elevation Myocardial Infarction
- Feasibility Study of Short Term Fondaparinux (Arixtra) in Chemotherapy-Pretreated Ovarian Carcinoma Patients at High Risk of Progression
- Coronary Bypass and Artotic Leaflet Surgery : Heparin Low Dose vs Full Dose
- Intravenous Heparin as an Adjunct for the Treatment of Anaphylactic Reactions in an Emergency Department
- PEITHO Pulmonary Embolism Thrombolysis Study
- Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of a New Ultra Low Molecular Weight Heparin (RO-14) Administered Subcutaneously Increasing Single-doses to Healthy Male Volunteers
- Innohep for Prophylaxis of Venous Thromboembolism in Brain Tumor Patients
- A Multi-Centered, Two-Arm, Randomized Study Comparing the Effects of AAT-023 (Zuragen) Solution, and Heparin on the Incidence of Catheter Related Blood Stream Infections in Tunneled Chronic Central Venous Catheters for Dialysis
- Evaluation of Long-Term Sequelae After Thrombophlebitis, i.e. Deep Venous Thrombosis of the Lower Extremities
- IV vs. IA tPA (Activase) in Acute Ischemic Stroke With CTA Evidence of Major Vessel Occlusion
- Study to Evaluate the Mortality Reduction of Enoxaparin in Hospitalized Acutely Ill Medical Receiving Enoxaparin
- Etude (Study) Phase I Enox - UnFractionated Heparin (UFH)
- Effects of LMWH in Healthy Subjects Treated With TB-402 and Effects of TB-402 in Healthy Subjects Treated With Warfarin
- Combination Therapy Using Cellcept and Rebif in RRMS
- Pegylated Liposomal Doxorubicin, Low Freq Dexamethasone & Revlimid (Dd-R) in Newly Diagnosed Multiple Myeloma (MM)
- ACRIPAB- Trial: Anti Coagulation Regimen In High Risk PAtients for Bleeding
- Fondaparinux in Patients With Acute Heparin-Induced Thrombocytopenia (HIT)
- APL93: Timing of CxT and Role of Maintenance
- Determining How Quickly Progesterone Slows LH Pulse Frequency
- FFA-Induced Hypertension and Endothelial Dysfunction
- Optimal Heparin Dosing Regimens for Cardiopulmonary Bypass
- Study to Evaluate Weight-based Enoxaparin Dosing in Obese Medical Patients at Risk for DVT
- Evaluation of a Simplified Protocol for Regional Citrate Anticoagulation in Continuous Venovenous Hemodiafiltration
- Prophylactic Antimicrobial Catheter Lock
- N-Acetyl Cysteine for Prevention of Preterm Birth
- Safety of High-dose Tirofiban During Coronary Angioplasty
- On Label, Randomized, Double-Blind, Placebo-Controlled Trial of Preoperative Finasteride in Patients Undergoing Transurethral Resection of the Prostate (TURP)
- Low Molecular Weight Heparin and Aspirin in the Treatment of Recurrent Pregnancy Loss: A RCT
- Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
- Local Versus Systemic Thrombolysis for Acute Ischemic Stroke (SYNTHESIS)
- Mechanism of Fatty Acid-induced Impairment of Glucose-simulated Insulin Secretion - Effect of Buphenyl
- The Use of Fondaparinux in Preventing Thromboembolism in High Risk Trauma Patients
- Sorafenib + Topotecan for Platinum-Resistant Recurrent Ovarian Cancer
- Cloretazine (VNP40101M) With Hematopoietic Cell Transplantation for Hematologic Malignancies
- Study on Safety and Effectiveness of Three Doses of Argatroban as Anticoagulant in Percutaneous Coronary Intervention (PCI)
- Perioperative Administration of COX 2 Inhibitors and Beta Blockers to Women Undergoing Breast Cancer Surgery
- A Randomised Study to Assess Betadine in the Groin Wound of Patients Undergoing Primary Varicose Vein Surgery
- Spironolactone for Reducing Proteinuria in Diabetic Nephropathy
- Cord Blood Expansion on Mesenchymal Stem Cells
- Anticoagulation in Blunt Cerebrovascular Injuries
- Bemiparin Randomized Trial on Bridging Oral Anticoagulants in Invasive Procedures (BERTA Study)
- Effects of Statin and Ezetimibe Association on Kinetics of Artificial Chilomicrons
- Effect of Low Molecular Weight Heparin: Tinzaparin in Lung Tumours (TILT)
- Allogeneic Stem Cell Transplantation for Myelofibrosis and Myelodysplastic Syndrome
- Fondaparinux to Prevent Thrombotic Complications and Graft Failure in Patients Undergoing Coronary Artery Bypass Graft Surgery: The Fonda CABG Study
- IV Busulfan With Allo-BMT: Study for Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome
- Busulfan, Fludarabine, Clofarabine With Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia
- Treatment of Acute Promyelocytic Leukemia With All-Trans Retinoic Acid (ATRA) and Idarubicin (AIDA)
- Switching From Fondaparinux to Bivalirudin or Unfractionated Heparin in ACS Patients Undergoing PCI
- A Study Designed to Evaluate ODSH in Subjects With Exacerbations of COPD
- A Comparison of Certoparin and Unfractionated Heparin in the Prevention of Thromboembolic Events in Acutely Ill Medical Patients
- Residual Vein Thrombosis and the Optimal Duration of Low Molecular Weight Heparin in Cancer Patients With Deep Vein Thrombosis
- Antithrombotic Regimens and Outcome
- Dalteparin vs Unfractionated Heparin For The Prevention Of Venous Thromboembolism (VTE) In Hospitalized Acutely Ill Medical Patients
- Comparison of Two Treatment Strategies in Patients With an Acute Coronary Syndrome Without ST Elevation
- HEROIC (Heparin Requirement in Counterpulsation)
- Enoxaparin Versus Unfractionated Heparin in PCI
- Thromboprophylaxis in Critically Ill Patients
- Dalteparin Versus Unfractionated Heparin In Patients With Acute Coronary Syndrome
- Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction
- PERIOP 2 - A Safety and Effectiveness of LMWH vs Placebo Bridging Therapy for Patients on Long Term Warfarin Requiring Temporary Interruption of Warfarin.
- Effect of Elevated Plasma-Free-Fatty-Acids on Renal Hemodynamic Parameters
- Treatment of Acute Respiratory Distress Syndrome With Tenecteplase: A Dose Escalation Pilot Study
- Liver Infusions of Fluorouracil in Treating Patients With Dukes' A, Dukes' B, or Dukes' C Colon Cancer Undergoing Surgery
- Effectiveness of Blood Clot Medication With Concomitant Blood Pressure Medication
- Low Molecular Weight Heparin vs Unfractionated Heparin at Cardiac Surgery
- Abciximab in Patients Undergoing Percutaneous Coronary Intervention for Cardiogenic Shock
- Study of Aspirin and TPA in Acute Ischemic Stroke
- Fondaparinux as Monotherapy for DVT and/or Pulmonary Embolism
- Once Daily Enoxaparin for Outpatient Treatment of Acute DVT and/or Pulmonary Embolism
- Pilot Dose Finding and Pharmacokinetic Study of Fondaparinux in Children With Thrombosis
- The Effects of Tirofiban in Diabetic Patients Undergoing Elective Percutaneous Coronary Intervention
- Effects of Tinzaparin on Cardio-vascular Outcomes and on Blood Lipids in Diabetic Patients on Chronic Hemodialysis
- An Oral, Direct Factor Xa Inhibitor, BAY59-7939, for Prophylaxis Against Venous Thromboembolism After Total Knee Replacement: a Dose-Ranging Study
- Effectiveness of Dalteparin Therapy as Intervention in Recurrent Pregnancy Loss
- Efficacy of a Low-Molecular-Weight Heparin (Bemiparin) in the Treatment of Chronic Foot Ulcers in Diabetic Patients
- Dose-Ranging Study of BAY 59-7939 on the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement
- Study of Tirofiban Administration in Patients With Aspirin and or Clopidogrel Resistance
- Once-daily Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Deep-vein Thrombosis
- Effect of Intraoperative Aprotinin Administration on Post Cardiac Surgery Optic Nerve and Retinal Thickness.
- Deferment of Imaging for Pulmonary Embolism
- Anti Ischemic Effects of Abciximab in Angioplasty and Stenting Patients
- Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection
- Is Using Fondaparinux (Blood Thinner) to Treat Lung Clot Cheaper Than Traditional Therapy
- PIoglitazone for PrEvention of Restenosis in Diabetic Patients
- Comparison of Two Different Dosages of Low-molecular Weight Heparin in Cancer Patients
- Randomized Comparison of Abciximab Plus Heparin With Bivalirudin in Acute Coronary Syndrome
- The Effect of 5-FU and LMW Heparin on the Rate of Retinal Redetachment After Silicone Oil Removal in Cases of PVR
- Oral Colchicine Combined With Intravitreal Infusion of Dexamethasone, LMW Heparin and 5-FU for Management of Proliferative Vitreoretinopathy (PVR)
- Peri-Procedural Myocardial Infarction, Platelet Reactivity, Thrombin Generation, and Clot Strength: Differential Effects of Eptifibatide + Bivalirudin Versus Bivalirudin
- Different Doses and Duration of Low Molecular Weight Heparin (Parnaparin)in Superficial Vein Thrombosis
- Substrate Cycling in Energy Metabolism
- Palifermin DDI (Drug Drug Interaction)
- Randomized Multicenter Trial of Prehospital Initiated Facilitated Percutaneous Coronary Intervention (PCI) Versus Primary PCI in ST-segment-Elevation MI (STEMI)
- Deep Vein Thrombosis (DVT) Prevention in Total Hip Arthroplasty: Continuous Enhanced Circulation Therapy (CECT) Versus Low Molecular Weight Heparin (LMWH)
- The Effect of Vasopressors on the Anti Xa Response to Enoxaparin in Critically Ill Patients
- Clinical Study Assessing Idrabiotaparinux Sodium Injections Once-weekly in Pulmonary Embolism Therapeutic Approach
- Study Comparing Desirudin With Heparin to Prevent Vein Clots After Heart and Lung Surgery
- Adjuvant BEmiparin in Small Cell Lung Carcinoma (ABEL STUDY)
- Studies of AQ-13, a Candidate Aminoquinoline Antimalarial, in Comparison With Chloroquine
- The AOT (Acridine Orange and Taurolidine) Trial
- LV Thrombus Pilot Study for Comparing Enoxaparin Vs. Warfarin
- Safety, Pharmacokinetics and Efficacy of an AT-III Concentrate.
- Study of Otamixaban Versus Unfractionated Heparin (UFH) and Eptifibatide in Non-ST Elevation Acute Coronary Syndrome
- RIAPRE - Non-interventional Registry of Anticoagulation Treatment (BI-006-IT)
- Efficacy and Safety of Low-molecular Weight Heparin for Thromboprophylaxis in Acutely Ill Medical Patients
- Prophylaxis of Venous Thrombo-Embolism in Cancer Patients Under Palliative Care
- ABRIDGE: Low Molecular Weight Heparin in Bridging Patients After Mechanical Valve Replacement
- Tinzaparin in Treating Patients With Metastatic Kidney Cancer That Cannot Be Removed By Surgery
- Randomized Study of Aspirin Resistant Patients Undergoing Angioplasty
- Assessment of Cardioversion Using Transesophageal Echocardiography II (ACUTE II)
- Safety and Efficacy of the Use of Regional Anticoagulation With Citrate in Continuous Venovenous Hemofiltration
- Association of L-asparaginase-Methotrexate-Dexamethasone for Nasal and Nasal-type Natural Killer (NK)-T-cell Lymphoma
- Innohep® in Elderly Patients With Impaired Renal Function Treated for Acute Deep Vein Thrombosis
- A Study Comparing the Efficacy and Safety of Intracoronary Stenting With or Without Abciximab, an Anti-Platelet Therapy, and Conventional Coronary Angioplasty With Abciximab
- A Study Comparing the Efficacy and Safety of Abciximab, an Anti-Platelet Therapy, in Combination With Two Different Heparin Regimens in Patients Undergoing Percutaneous Coronary Intervention.
- Management of Superficial Thrombophlebitis
- Un-fractionated Heparin Versus Bivalirudin During Percutaneous Coronary Interventions (PCI) (ISAR-REACT-3)
- LMWH to Prevent Preeclampsia and Fetal Growth Restriction
- Thrombolysis Versus Primary Angioplasty for AMI in Elderly Patients
- Study of U101 for Bladder Pain and/or Urgency
- Fondaparinux as an Anticoagulant in Haemofiltration in Patients With Acute Kidney Failure.
- Patients Preference With Self-Injection: The PRISM Study
- Oral Direct Factor Xa-inhibitor Apixaban in Patients With Acute Symptomatic Deep-vein Thrombosis-The Botticelli DVT Study
- Aggrastat to Zocor (AtoZ) - the Use of Two Approved Drugs to Treat Patients Who Have Experienced Chest Pain or a Heart Attack (0733-180)
- To Determine the Feasibility of a Clinical Trial Comparing Anticoagulants Versus Antiplatelets in the Acute Treatment of Patients With Cervical Artery Dissection
- Risk of Developing Antibodies to Heparin-PF4 After Heart Surgery
- Cisplatin, Gemcitabine and Bevacizumab in Combination for Metastatic Transitional Cell Cancer
- Defined Green Tea Catechin Extract in Preventing Esophageal Cancer in Patients With Barrett's Esophagus
- The STOP CLOT Pilot Study: Study of Low Molecular Weight Heparin in High Risk Cesarean Section
- Aspirin for the Prevention of Recurrent Venous Thromboembolism
- Tenecteplase Pulmonary Embolism Italian Study
- The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis
- Phase I/II Trial of Infusional Gemcitabine in Combination With Carboplatin in Chemonaive Non-small Cell Carcinoma
- Assessment of Long-Term Out-of-Hospital Treatment of Patients With Proximal Deep Vein Thrombosis (DVT) Using Low-Molecular-Weight Heparin (LMWH) Versus LMWH Followed by Warfarin
- Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study)
- Efficacy and Safety Study of Argatroban to Treat Heparin-Induced Thrombocytopenia
- Impact of Heparin on the Need for Mechanical Ventilation in Neonates
- The HIT-TRAP Trial
- Mechanism of Fatty Acid-Induced Impairment of Glucose-Stimulated Insulin Secretion
- The D-KAF (Dalteparin in Knee-to-Ankle Fracture) Trial
- Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney Failure
- Fixed Dose Heparin Study
- PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT Pilot)
- PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT)
- International Multi Centre Randomized Clinical Trial Of Anticoagulation In Children Following Fontan Procedures
- Steroids and Antiphospholipid Syndrome- Related Pregnancy Loss
- Stroke Prevention With Abciximab in Carotid Endarterectomy
- Atrial Fibrillation Feasibility Certoparin Trial - AFFECT
- The Use of Low Molecular Weight Heparin in Traumatic Brain Injury
- A Trial Evaluating the Efficacy and Safety of Tenecteplase Together With Unfractionated Heparin Prior to Early Percutaneous Coronary Intervention (PCI) as Compared to Standard Primary PCI in Patients With Acute Myocardial Infarction (ASSENT 4 PCI)
- A Trial of Doxil and Multiday Vinorelbine in Patients With Metastatic Breast Cancer
- Platelet Function And Aggregometry In Patients With Aortic Valve Stenosis
- Determining the Responsiveness of Intestinal Lipoprotein Production to an Elevation of Plasma Free Fatty Acids
- Dalteparin's Influence on Renally Compromised: Anti-Ten-A Study (DIRECT)
- Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients
- MesoHep II: Intraperitoneal Low Molecular Weight Heparin in Peritoneal Dialysis
- The SEPIA-PCI Trial: Otamixaban in Comparison to Heparin in Subjects Undergoing Non-Urgent Percutaneous Coronary Intervention
- Abciximab, Clopidogrel and Percutaneous Coronary Intervention in Acute Coronary Syndrome (ISAR-REACT-2)
- Effect of Sulodexide in Early Diabetic Nephropathy
- Abciximab for Prevention of Stroke Recurrence Before Endarterectomy in Symptomatic Carotid Stenosis
- Hexadecasaccharide (SR123781A) in Patients With Unstable Angina or Non-ST-Segment Elevation Myocardial Infarction
- Anticoagulation With rNAPc2 to Eliminate MACE/TIMI 32
- Safety and Dosing Evaluation of REG1 Anticoagulation System
- Acamprosate to Reduce Symptoms of Alcohol Withdrawal
- Zinc Homeostasis and Kinetics in Children With Cystic Fibrosis (CF)
- Unfractioned Heparin for Treatment of Sepsis
- Comparison of Angiomax Versus Heparin in Acute Coronary Syndromes (ACS)
- EARLY ACS: Early Glycoprotein IIb/IIIa Inhibition in Patients With Non-ST-segment Elevation Acute Coronary Syndrome (Study P03684AM2)(COMPLETED)
- Low-Dose Alteplase to Treat Blood Clots in Deep Leg Veins
- Comparing Angiomax to Heparin With Protamine in Patients Undergoing Cardiopulmonary Bypass (CPB)
- Angiomax in Patients With HIT/HITTS Type II Undergoing CPB
- Safety and Efficacy of Enoxaparin in Percutaneous Coronary Intervention (PCI) Patients, an International Randomized Evaluation (STEEPLE)
- Enoxaparin Versus Unfractionated Heparin in Subjects Who Present to the Emergency Department With Acute Coronary Syndrome (RESCUE)
- PREVAIL: PREvention of VTE After Acute Ischemic Stroke With LMWH Enoxaparin ( - VTE: Venous Thromboembolism - LMWH: Low Molecular Weight Heparin)
- Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment Thrombolysis in Myocardial Infarction - Study 25 (ExTRACT-TIMI25)
- EXCLAIM:Extended Prophylaxis for Venous ThromboEmbolism (VTE) in Acutely Ill Medical Patients With Prolonged Immobilization
- Rimonabant to Reduce Alcohol Consumption
- A Clinical Study to Assess the Safety of PEG-Hirudin (SPP200) Compared to Heparin in Patients Who Are on Haemodialysis
- Comparing Angiomax to Heparin With Protamine Reversal in Patients OPCAB
- Angiomax in Patients With HIT/HITTS Type II Undergoing Off-Pump Coronary Artery Bypass Grafting (CABG) (CHOOSE)
- Safety and Efficacy Trial Evaluating the Use of SR34006 in the Treatment of Deep Vein Thrombosis (DVT)
- SR34006 Compared to Vitamin K Antagonist (VKA) in the Treatment of Pulmonary Embolism
- Combination Anti-Platelet and Anti-Coagulation Treatment After Lysis of Ischemic Stroke Trial (CATALIST)
- A Safety and Efficacy Trial Evaluating the Use of Fondaparinux in Percutaneous Coronary Intervention (PCI)(63133)(WITHDRAWN)
- Effect of Talampanel (an AMPA Receptor Blocker) on Brain Activity
- A Trial of Heparin in Patients With Severe Sepsis Who Are Undergoing Treatment With Drotrecogin Alfa (Activated)
- Depsipeptide to Treat Thyroid and Other Advanced Cancers
- Anticoagulant Therapy With Bivalirudin in the Performance of Percutaneous Coronary Intervention in Patients With Heparin-Induced Thrombocytopenia (AT BAT, First Inning)
- SYNERGY: Open Study of Enoxaparin Versus Unfractionated Heparin in Patients With Acute Coronary Syndromes
- Study Of Angiomax In Infants Under Six Months With Thrombosis
- Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin
- Heparin Versus Lepirudin Flushes in Preventing Blockage of Venous Access Devices
- Megadose CD34 Selected Progenitor Cells for Transplantation in Patients With Advanced Hematological Malignant Diseases
- Thalidomide-Dexamethasone for Multiple Myeloma
- Safety and Efficacy of OP2000 (Deligoparin) in the Treatment of Active Ulcerative Colitis
- Tenofovir Disoproxil Fumarate to Treat Pediatric HIV
- Islet Transplantation for Type 1 Diabetes
- Capravirine to Treat Children With HIV Infection
- Oral Anticoagulant Therapy for Venous Thrombosis - SCOR in Thrombosis
- Heparin or Enoxaparin in Patients With Cancer
- Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Iloprost for Raynaud's Phenomenon Secondary to Systemic Sclerosis
- Study of Heparin Prophylaxis of Hereditary Angioedema Exacerbations
- Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer
- Once-Daily Drug Regimen for HIV-Infected Patients
- Treatment for Blood Clots in the Veins of the Legs
- Prevention of Recurrent Venous Thromboembolism (PREVENT)
- Intravenous Streptokinase in Acute Myocardial Infarction
- Randomized Clinical Trial of Non-Surgical Reperfusion of the Coronary Arteries
- Do Fish Oils Prevent Restenosis Post-Coronary Angioplasty?
- Thrombolysis in Myocardial Ischemia Trial (TIMI III)
- Asymptomatic Carotid Artery Plaque Study (ACAPS)
- Myocardial Infarction Triage and Intervention Project (MITI)
- Postmenopausal Estrogen/Progestin Interventions (PEPI)
Clinical trials list
click for details